The novel choline kinase inhibitor ICL-CCIC-0019 reprograms cellular metabolism and inhibits cancer cell growth. (2016)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.9466
PubMed Identifier: 27206796
Publication URI: http://europepmc.org/abstract/MED/27206796
Type: Journal Article/Review
Volume: 7
Parent Publication: Oncotarget
Issue: 24
ISSN: 1949-2553